Palabras clave
Microbiota
Intestino Irritable
Salud Intestinal
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Abordar la relación entre la Fibromialgia (FM) y la salud del tracto gastrointestinal (TGI) y su importancia para el diagnóstico y tratamiento de la FM. Revisión bibliográfica: La FM es una condición reumatológica caracterizada principalmente por dolor crónico difuso. Otras posibles manifestaciones incluyen fatiga, trastornos del sueño, deterioro cognitivo, trastornos del estado de ánimo y síntomas gastrointestinales. Existe una relación muy estrecha entre la FM y los trastornos gastrointestinales y un diagnóstico bien hecho, así como una buena evaluación del paciente, son necesarios para lograr el mejor resultado terapéutico posible. Consideraciones finales: Aunque poco aclarada, existe una estrecha correlación entre la FM y el TGI. Por eso, es importante valorar la sintomatología y conocer la relación bidireccional entre la FM y los trastornos gastrointestinales, especialmente el síndrome del intestino irritable (SII). Sin embargo, son necesarios más estudios que exploren la etiopatogenia y fisiopatología de la FM, así como la influencia del TGI en estos aspectos, con el fin de mejorar tanto el diagnóstico como el tratamiento de la FM.
Referencias
ALBAYRAK B, et al. Investigating of relation between fibromyalgia syndrome and intestinal microbiota. Mikrobiyol Bul, 2021; 55(2): 146-160.
ALBRECHT PJ e RICE FL. Fibromyalgia syndrome pathology and environmental influences on afflictions with medically unexplained symptoms. Rev Environ Health, 2016; 31(2): 281-294.
ATZENI F, et al. Rheumatic manifestations in inflammatory bowel disease. Autoimmun Rev, 2014; 13(1): 20-23.
BAYRAK M. Metabolic syndrome, depression, and fibromyalgia syndrome prevalence in patients with irritable bowel syndrome: A case-control study. Medicine (Baltimore), 2020; 99(23): e20577.
BERSTAD A, et al. Functional bowel symptoms, fibromyalgia and fatigue: A food-induced triad?. Scand J Gastroenterol, 2012; 47(8-9): 914-919.
CHEN JH, et al. Is Fibromyalgia Risk Higher Among Male and Young Inflammatory Bowel Disease Patients? Evidence from a Taiwan Cohort of One Million. Pain Physician, 2018; 21(3): 257-264.
CLOS-GARCIA M, et al. Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine, 2019; 46(1): 499-511.
ERDRICH S, et al. A systematic review of the association between fibromyalgia and functional gastrointestinal disorders. Therapeutic Advances in Gastroenterology, 2020; 13: 1-17.
ERDRICH S, et al. Determining the association between fibromyalgia, the gut microbiome and its biomarkers: A systematic review. BMC Musculoskelet Disord, 2020; 21(181): 1-12.
FREIDIN MB, et al. An association between chronic widespread pain and the gut microbiome. Rheumatology (Oxford), 2021; 60(8): 3727-3737.
GALVEZ-SÁNCHEZ CM, et al. Psychological impact of fibromyalgia: current perspectives. Psychol Res Behav Manag, 2019; 12(1): 117-127.
GARCÍA-LEIVA JM, et al. Celiac symptoms in patients with fibromyalgia: a cross-sectional study. Rheumatology International, 2014; 35(3): 561-567.
GOTA CE. Fibromyalgia Recognition and Management in the Primary Care Office. Med Clin North Am, 2021; 105(2): 285-296.
HAUSTEINER-WIEHLE C e HENNINGSEN P. Irritable bowel syndrome: Relations with functional, mental, and somatoform disorders. World J Gastroenterol, 2014; 20(20): 6024-6030.
HEIDARI F, et al. Prevalence of fibromyalgia in general population and patients, a systematic review and meta‐analysis. Rheumatol Int, 2017; 37(9): 1527-1539.
HEYMANN RE, et al. Consenso brasileiro do tratamento da fibromialgia. Rev Bras Reumatol, 2010; 50(1): 56-66.
HEYMANN RE, et al. Novas diretrizes para o diagnóstico da fibromialgia. Rev Bras Reumatol, 2017; 57(2): 467-476.
HOD K, et al. Bloating in Irritable Bowel Syndrome Is Associated with Symptoms Severity, Psychological Factors, and Comorbidities. Digestive Diseases and Sciences, 2018; 64(5): 1288-1295.
JOHNSON CM e MAKAI GEH. Fibromyalgia and Irritable Bowel Syndrome in Female Pelvic Pain. Semin Reprod Med, 2018; 36(2): 136-142.
KLEYKAMP BA, et al. The Prevalence of Psychiatric and Chronic Pain Comorbidities in Fibromyalgia: an ACTTION systematic review. Semin Arthritis Rheum, 2021; 51(1): 166-174.
KOECHLIN H, et al. Placebo responses and their clinical implications in fibromyalgia: a meta-analysis using SSRI and SNRI trials. Front Pain Res (Lausanne), 2021; 2:750523.
MACFARLANE GJ, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis, 2017; 76(2): 318-328.
MCCARBERG BH. Clinical overview of fibromyalgia. Am J Ther, 2012; 19(5): 357-368.
MINERBI A, et al. Altered microbiome composition in individuals with fibromyalgia. Pain, 2019; 160(11): 2589-2602.
MINERBI A e FITZCHARLES MA. Gut microbiome: pertinence in fibromyalgia. Clin Exp Rheumatol, 2020; 123(1): 99-104.
NISIHARA R, et al. Celiac disease and fibromyalgia: Is there an association?. Rev Esp Enferm Dig, 2016; 108(2): 107-108.
OLIVE LS, et al. Fatigue, Physical Activity, and Mental Health in People Living With Inflammatory Bowel Disease, Fibromyalgia, and in Healthy Controls: A Comparative Cross-Sectional Survey. Gastroenterol Nurs, 2020; 43(2): 172-185.
OTU-NYARKO CG, et al. Disability in Children and Adolescents With Irritable Bowel Syndrome and/or Fibromyalgia. J Pediatr Gastroenterol Nutr, 2015; 61(5): 558-560.
PEARSON J, et al. A feasibility randomised controlled trial of a fibromyalgia self- management programme in a community setting with a nested qualitative study (FALCON): Study protocol. Musculoskeletal Care, 2021; 19(1): 59-66.
RODRIGO L, et al. Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study. Arthritis Res Ther, 2013; 15(6): 1-12.
SETTEMBRE C, et al. Association among Disorders of Gut-Brain Interaction (DGBI) and Fibromyalgia: A Prospective Study. J Clin Med, 2022; 11(3): 809.
SIRACUSA R, et al. Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. Int J Mol Sci, 2021; 22(8): 3891.
SLIM M, et al. An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms. Rheumatol Int, 2015; 35(3): 433-444.
TECKCHANDANI S, et al. Metabolomics in Chronic Pain Research. Eur J Pain, 2021; 25(2): 313-326.
TOMASELLO G, et al. Intestinal dysbiosis and hormonal neuroendocrine secretion in the fibromyalgic patient. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2018; 162(4): 258-262.
TOVOLI F, et al. Fibromyalgia and coeliac disease: a media hype or an emerging clinical problem?. Clin Exp Rheumatol, 2013; 31(6): 50-52.
ÜÇÜNCÜ MZ, et al. The early diagnosis of fibromyalgia in irritable bowel syndrome patients. Medical Hypotheses, 2020; 143:110119.
WOLFE F, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Seminars in Arthritis and Rheumatism, 2016; 46(3): 319-329.
WOLFE F, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care & Research, 2010; 62(5): 600-610.
YANG TY, et al. Risk for Irritable Bowel Syndrome in Fibromyalgia Patients: A National Database Study. Medicine (Baltimore), 2017; 96(14): e6657.